Ocugen, Inc. (OCGN)
1.30
+0.07
(+5.69%)
USD |
NASDAQ |
Dec 11, 16:00
1.31
+0.01
(+0.77%)
After-Hours: 05:25
Ocugen Research and Development Expense (Quarterly): 10.20M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Belite Bio, Inc. | 10.31M |
| MannKind Corp. | 14.06M |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| CorMedix, Inc. | 5.098M |
| Verastem, Inc. | 28.99M |